From February 6, 2024 to March 31, 2024, the company has repurchased 849,300 shares, representing 0.15% for CNY 14.12 million. With this, the company has completed the repurchase of 849,300 shares, representing 0.15% for CNY 14.12 million under the buyback announced on February 7, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.05 CNY | -1.33% | +2.19% | -2.29% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.29% | 1.62B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
-2.71% | 159B |
- Stock Market
- Equities
- 600557 Stock
- News Jiangsu Kanion Pharmaceutical Co.,Ltd.
- Tranche Update on Jiangsu Kanion Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on February 7, 2024.